Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes
Acta Neurologica Belgica · 2024
DOI: 10.1007/s13760-024-02597-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Belgica, 2024. Verfasst von Ana Turčić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, HR-10 000, Croatia. ana.turcic@kbc-zagreb.hr. Hauptthemen laut MEDLINE: Immunoglobulin G. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The difference in the clinical course, response to therapy, and distribution of CNS inflammation in primary-progressive (PPMS) and relapsing-remitting multiple sclerosis (RRMS) suggests differences in the underlying immunological characteristics of the disease. We aimed to investigate differences in immunological profiles in relation to intrathecal inflammation in different MS forms. METHODS: The peripheral blood (PB) proportions of CD4 + and CD8 + T-cells and CD19 + B-cells were retrospectively compared with the markers of intrathecal immunoglobulin G (IgG) synthesis at diagnosis: IgG index, percentage of intrathecal IgG synthesis (IF IgG), the number of oligoclonal bands (OCB), depending on the blood-brain barrier (BBB) function, and antibody specific index to neurotrophic viruses (MRZH reaction). RESULTS: Thirty-six controls, 71 RRMS and 25 PPMS were enrolled. PPMS had higher percentage of CD4 + T-cells compared to RRMS (P = 0.043) and controls (P = 0.003). The percentage of CD8 + T-cells and CD19 + B-cells, and respective absolute cell counts did not differ according to the MS phenotype. In RRMS with the dysfunctional BBB, the IgG index (r = 0.642, P = 0.012) correlated significantly with the CD19 + B-cells while the CD4 + T-cells inversely correlated with IF IgG (r=-0.574, P = 0.039). Interestingly, in PPMS the number of OCB was positively associated with CD4+ (r = 0.603, P = 0.015) and negatively associated with CD8 + T-cells (r=-0.554, P = 0.033), while IF IgG negatively correlated with CD8 + T-cells (r=-0.689, P = 0.003), but only in the preserved BBB function. CONCLUSIONS: The PB CD4 + T-cells and B-cells were associated with the intrathecal inflammation in RRMS with BBB dysfunction while CD8 + T-cells were involved in PPMS with CNS-compartmentalized inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, HR-10 000, Croatia. ana.turcic@kbc-zagreb.hr.
- Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, HR-10 000, Croatia.
- Department of Neurology, University of Zagreb School of Medicine, Zagreb, Croatia.
- Referral Center for Autonomic Nervous System Disorders, Department of Neurology, University Hospital Centre Zagreb, Zagreb, Croatia.
- Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia.
Zitieren
APA
Turčić, A., Knežević, J., Zaninović, L., Habek, M., Skorić, M. K., Babić, A., & Vogrinc, Ž. (2024). Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-024-02597-8
Vancouver
Turčić A, Knežević J, Zaninović L, Habek M, Skorić MK, Babić A, et al. Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes. Acta Neurologica Belgica. 2024. doi:10.1007/s13760-024-02597-8
BibTeX
@article{Turi2024,
author = {Turčić, Ana and Knežević, Josip and Zaninović, Ljiljana and Habek, Mario and Skorić, Magdalena Krbot and Babić, Antonija and Vogrinc, Željka},
title = {Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes},
journal = {Acta Neurologica Belgica},
year = {2024},
doi = {10.1007/s13760-024-02597-8}
}
EUVIMED